Regulatory T cells in skin lesions and blood of patients with bullous pemphigoid

Background Although regulatory T cells (Tregs) are affected in several autoimmune skin diseases, only two studies have been performed in patients with bullous pemphigoid (BP) with contrasting results. Objective To characterize Tregs and to determine the serum levels of regulatory cytokines in patien...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Journal of the European Academy of Dermatology and Venereology 2014-02, Vol.28 (2), p.222-230
Hauptverfasser: Antiga, E., Quaglino, P., Volpi, W., Pierini, I., Del Bianco, E., Bianchi, B., Novelli, M., Savoia, P., Bernengo, M.G., Fabbri, P., Caproni, M.
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:Background Although regulatory T cells (Tregs) are affected in several autoimmune skin diseases, only two studies have been performed in patients with bullous pemphigoid (BP) with contrasting results. Objective To characterize Tregs and to determine the serum levels of regulatory cytokines in patients with BP. Methods In BP lesional skin, immunohistochemistry and confocal microscopy were performed for CD4+, CD25+, forkhead/winged helix transcription factor (FOXP3)+, transforming growth factor (TGF)‐β+ and interleukin (IL)‐10+ cells. In addition, the number of CD4+CD25++FOXP3+ Tregs in peripheral blood was assessed by flow cytometry, and the levels of TGF‐β and IL‐10 were determined in serum samples by enzyme‐linked immunosorbent assay before and after steroid therapy. Controls included patients with psoriasis, atopic dermatitis (AD) and healthy donors. Results The frequency of FOXP3+ cells was significantly reduced in skin lesions from patients with BP (P 
ISSN:0926-9959
1468-3083
DOI:10.1111/jdv.12091